Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Hif1a gene in Microglia: A hope for Alzheimer’s patients

“Yellow Fungus” emerges a bigger threat in Ghaziabad

Protein Kinase CK2 : The drug target for diverse human disorders

Hif1a gene in Microglia:  A hope for Alzheimer’s patients
  • BiotechToday
  • World

Hif1a gene in Microglia: A hope for Alzheimer’s patients

bioxone May 28, 2021May 28, 2021

Aakancha Shaw, St. Xavier’s College, Kolkata

When we talk about the most common form of dementia Alzheimer’s Disease comes to our mind. This disease is characterized by the build-up of amyloid plaque in the brain. Microglia that are considered to be the immune Sentinels of the brain not only eliminate foreign invaders but are also responsible for maintaining brain homeostasis by clearing toxic waste build-up such as amyloid plaques. However, the role of microglia in Alzheimer’s Disease and clearing toxic waste and its role and relationship to amyloid plaque accumulation remains unclear. A team of scientists from Duke-NUS Medical School and MonashUniversity found that the gene expression signatures underlying microglia are known to be associated with amyloid plaque phagocytosis which is the engulfing of deposits of the amyloid-beta protein in the brain. The finding was reported in the journal Nature communication. The Journal offered a new target for interventions that aimed to address the underlying disease mechanism of the incurable disease named Alzheimer’s Disease. The team of scientists at Monash and Duke-NUS investigated to find out the difference between a healthy brain and the brains of patients with Alzheimer’s disease at the single-cell resolution. The scientists took a resolution to study gene expression changes in specific human brain cell types comprehensively that are associated with the progression of Alzheimer’s Disease. They were trying to understand the molecular mechanisms and the differences between and microglia that were engulfing amyloid plaques in Alzheimer’s disease and the ones that were not.

The team did this experiment by using a stain known as methoxy-XO4, which is specifically known to target microglia that have engulfed amyloid plaques. They made use of the stain in preclinical models of Alzheimer’s disease and then extensively examined gene expression in the stained microglia. After this, they investigated differences in gene expression underlying microglia’s ability to amyloid plaque and identified associated regulatory molecules. The was important to understand that mechanism because there were several new targets to go after and in the future the targets night open up a new front against this devastating disease. The studies and experiments revealed that microglia that had not taken up the amyloid plaques had their gene expression patterns almost similar to aged microglia which are known to be dysfunctional and is a major factor in Alzheimer’s disease pathogenesis. Also, after the microglia engulfed the amyloid plaques associated with the disease they seemed to develop a characteristic expression pattern, this change in gene expression is induced by a gene called hif1a. The changed gene expression was known to increase the ability of microglia to take up proteins such as amyloid while reducing hif1a decreases the ability of microglia to take up such proteins. Hence, the regulatory role of hf1a might also apply to the microglia function of eliminating damaged synapses. Hence, this process may be initially protective with the microglia effectively pruning damaged synapses that are located near the plaques. The relationship between Hif1a and cognitive decline in Alzheimer’s disease is yet to be comprehensively studied to uncover a lot of facts.

Also read:“Yellow Fungus” emerges a bigger threat in Ghaziabad

Source: Grubman, A., Choo, X.Y., Chew, G. et al. Transcriptional signature in microglia associated with Aβ plaque phagocytosis. Nat Commun 12, 3015 (2021). https://doi.org/10.1038/s41467-021-23111-1

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

One thought on “Hif1a gene in Microglia: A hope for Alzheimer’s patients”

  1. Pingback: Protein Kinase CK2 : The drug target for diverse human disorders - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Protein Kinase CK2 : The drug target for diverse human disorders

bioxone May 28, 2021

Rohit Bhattacharjee, Amity University, Kolkata CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates many substrates, controls signaling pathways, implicates plenty of human sicknesses. Its best-recorded job is in cancer, where it manages every single hallmark of malignancy. Other notable functions of CK2 are in human diseases; specifically, viruses in viral infections misuse host […]

Protein Kinase

Related Post

  • BiotechToday
  • World

Researchers revert damage to eyesight in mice and predict reverse aging.

bioxone December 9, 2020December 9, 2020

Surupa Chakraborty, Amity University Kolkata Scientists cured lost eyesight in mice by genetically reprogramming the neurons that make up the optic nerve. They used the mice eye as a model tissue to show that the ectopic expression of genes like Oct4, Sox2, and Klf4 (OSK) in mouse retinal ganglion cells can help in restoring vision […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Wildfire smoke have significant influence on clouds

BioTech Today August 24, 2021August 23, 2021

Nandini Pharasi, Jaypee Institute of Information Technology Drying environments burn more easily, and rainwater can assist put out existing flames. However, wildfire fumes may prevent that much-needed rain from dropping. When wildfires release smoke into the atmosphere, fine particles accompany it. Water molecules can condense onto cloud particles. Concerns are all about droughts are escalating […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Are COVID-19 patients diagnosed with Down Syndrome prone to severe diseases?

bioxone October 18, 2020October 18, 2020

Sayak Banerjee, Amity University Kolkata Down syndrome (DS), also known as trisomy 21 is the most persistent aneuploidy characterized by a genetic disorder caused due to the triplication of the 21st human chromosome. This syndrome is particularly associated with the development of congenital heart disease, sleep apnoea, obesity, diabetes, premature ageing, and higher sensitivity to […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy